(2R,5S)-Ritlecitinib (Synonyms: (2R,5S)-PF-06651600) |
Catalog No.GC62130 |
Le (2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) est un inhibiteur puissant et sélectif de JAK3 (IC50=144,8 nM) extrait du brevet US20150158864A1, exemple 68.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1792180-79-0
Sample solution is provided at 25 µL, 10mM.
(2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) is a potent and selective JAK3 inhibitor (IC50=144.8 nM) extracted from patent US20150158864A1, example 68[1].
[1]. Atli Thorarensen, et al. Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyr-rolo[2,3-d]pyridinyl acrylamides. US20150158864A1.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *